OneMedNet Signs 12th Channel Partner as Global Pharma Intelligence Firm Takes Its Real-World Data Worldwide
MINNEAPOLIS — OneMedNet Corporation (Nasdaq: ONMD), a health data company headquartered in Minneapolis, Hennepin County, Minnesota, announced on October 19 that it has signed a channel partner agreement with a global provider of pharmaceutical intelligence and data solutions, which will distribute OneMedNet's clinical Real-World Data (RWD) to its pharmaceutical customers worldwide. It is the company's 12th channel partnership; the announcement did not name the partner.
OneMedNet said its data is sourced directly from U.S. healthcare providers rather than intermediaries and is de-identified at the source, at regulatory-grade quality. The partner will pair the multimodal clinical data with its own analytics and intelligence offerings to support pharmaceutical customers across drug development, regulatory submissions, market access and medical SI.
The company said data partners increasingly choose its Real-World Data for those qualities, and that the channel strategy extends its commercial reach while it keeps direct control of data sourcing, curation and de-identification.
According to Coherent Market Insights, the global Real-World Data market is estimated at about US$2.7 billion in 2026 and is projected to reach US$7.1 billion by 2033, as pharmaceutical companies rely more heavily on such data for development and commercial decisions. (GSM, based on the company's GlobeNewswire announcement)
Source: GSM · USA (original Chinese edition)
Photo: 跨密西西比河眺望明尼阿波利斯市中心天际线（资料图）。Guywelch2000 摄，CC BY 4.0，经 Wikimedia Commons 发布。Downtown Minneapolis skyline across the Mississippi River. Photo by Guywelch2000, CC BY 4.0, via Wikimedia Commons.
